Production (Stage)
Applied Therapeutics, Inc.
APLT
$0.4099
-$0.0001-0.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.83M | 44.01M | -68.59M | 2.90M | -83.94M |
| Total Depreciation and Amortization | 104.00K | 80.00K | 104.00K | 122.00K | 120.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.71M | -69.04M | 42.17M | -20.80M | 66.04M |
| Change in Net Operating Assets | -5.20M | 5.49M | 2.99M | -4.81M | -1.14M |
| Cash from Operations | -28.64M | -19.47M | -23.33M | -22.60M | -18.91M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -311.00K |
| Issuance of Common Stock | -- | 0.00 | 0.00 | -- | 115.81M |
| Repurchase of Common Stock | -- | -- | -- | -1.69M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 0.00 | -1.69M | 115.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.64M | -19.47M | -23.33M | -24.29M | 96.59M |